hemaCORE MDS extended Panel – 8 markers

Description

hemaCORE MDS (Myelodysplastic Syndrome) panel by FISH (Fluorescence In Situ Hybridization) detects specific chromosomal abnormalities associated with MDS. The panel includes analysis of Monosomy 5/Del(5q), Monosomy 7/Del(7q), Trisomy 8, Del(20q), Monosomy 13/Del(13q) (RB1), Monosomy 17/Del(17p) (TP53), MLL breakapart/11q23 related translocation, and MECOM breakapart/Inv(3). These tests aid in the diagnosis, risk stratification, and prognostication of MDS patients. Detecting these chromosomal abnormalities provides valuable information for treatment decisions, including the use of targeted therapies, risk-adapted strategies, and determining the patient’s overall prognosis and survival outcome.